Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Teva sees U.S. approval of three times weekly Copaxone soon
Teva sees U.S. approval of three times weekly Copaxone soon
Teva sees U.S. approval of three times weekly Copaxone soon
Submitted by
admin
on January 14, 2014 - 4:32pm
Source:
Reuters
News Tags:
Teva
FDA
Copaxone
MS
multiple sclerosis
Headline:
Teva sees U.S. approval of three times weekly Copaxone soon
Do Not Allow Advertisers to Use My Personal information
